Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 1997

View Archived Issues

Improved fibrinogen antagonists from DuPont Merck

Excitatory amino acid receptor ligands from Schering AG

FPTase inhibitors in early development at Merck & Co.

Hoechst reports new Na+/K+-exchange inhibitors

Therapeutically active PTH derivatives reported by Takeda

NK1 antagonists from Takeda

Antithrombotics described by Terumo

Sumitomo claims antiplatelet agents

Kotobuki discloses muscarinic antagonists

Sagami reports novel antitumor agents

Combination therapy for HCV

5-LO inhibitor not effective in psoriasis

Peptide Therapeutics and Medeva collaborate on vaccine development

Development of Hepagene progresses

Medeva begins full development of ADHD Rx

New approach to arrhythmia using novel SKB compound

Pharmos allowed patent for tamoxifen analogues

Allelix/Aurora enter drug discovery collaboration

Company Profile: Essential Nutrition

Allelix and Pharm-Eco form joint venture

Spotlight on CCK-B antagonists for anxiety

Promising findings reported for senescence genes

FDA to review generic immunosuppressant

Promising new Sawai antiulcer drug shows excellent results in rats

Research shows antibodies associated with resistance to AIDS

BMS/Xenova collaborate on drug discovery

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...